Evidence map›Paper›PMID 35072802›Full record

ArticleEJNMMI research2022

Validation and test-retest repeatability performance of parametric methods for [

Hayel Tuncel, Ronald Boellaard, Emma M Coomans, Marijke den Hollander-Meeuwsen, Erik F J de Vries, Andor W J M Glaudemans, Paula Kopschina Feltes, David Vállez García, Sander C J Verfaillie, Emma E Wolters and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Assessment of cerebral drug occupancy in humans using a single PET-scan: A [European journal of nuclear medicine and molecular imaging · 2024
    Observational
  2. Article
  3. Article
  4. Longitudinal Synaptic Loss in Primary Tauopathies: An In Vivo [Movement disorders : official journal of the Movement Disorder Society · 2023
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Hayel TuncelDepartment of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam UMC, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. h.tuncel@amsterdamumc.nl.
Ronald BoellaardDepartment of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam UMC, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Emma M CoomansDepartment of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam UMC, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Marijke den Hollander-MeeuwsenDepartment of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam UMC, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Erik F J de VriesDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center, University of Groningen, Groningen, The Netherlands.
Andor W J M GlaudemansDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center, University of Groningen, Groningen, The Netherlands.
Paula Kopschina FeltesDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center, University of Groningen, Groningen, The Netherlands.
David Vállez GarcíaDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center, University of Groningen, Groningen, The Netherlands.
Sander C J VerfaillieDepartment of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam UMC, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Emma E WoltersDepartment of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam UMC, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Steven P SweeneyRodin Therapeutics Inc., Cambridge, MA, USA.
J Michael RyanRodin Therapeutics Inc., Cambridge, MA, USA.
Magnus IvarssonRodin Therapeutics Inc., Cambridge, MA, USA.
Berkley A LynchRodin Therapeutics Inc., Cambridge, MA, USA.
Patrick SchoberDepartment of Anaesthesiology, Amsterdam UMC, Amsterdam, The Netherlands.
Philip ScheltensAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Amsterdam, The Netherlands.
Robert C SchuitDepartment of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam UMC, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Albert D WindhorstDepartment of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam UMC, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Peter P De DeynDepartment of Neurology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Bart N M van BerckelDepartment of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam UMC, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Sandeep S V GollaDepartment of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam UMC, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[

Indexed as

[11C]UCB-JAlzheimer’s diseaseParametric methodsPETSV2A

Identifiers

PMID35072802
PMCPMC8786991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.